Repligen Corp. (RGEN)
114.20
+0.44
(+0.39%)
USD |
NASDAQ |
Mar 13, 16:00
115.01
+0.81
(+0.71%)
After-Hours: 07:28
Repligen Profit Margin (Quarterly) : 6.71% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Masimo Corp. | 15.01% |
| Orthofix Medical, Inc. | -1.01% |
| InfuSystem Holdings, Inc. | 5.62% |
| Tandem Diabetes Care, Inc. | -0.20% |
| Plus Therapeutics, Inc. | -417.9% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.39% |
| Return on Assets | 1.69% |
| Return on Invested Capital | 1.79% |
| Gross Profit Margin (Quarterly) | 47.21% |
| Operating Margin (Quarterly) | 9.38% |
| Return on Net Operating Assets | 2.30% |